Insulet is a major player when it comes to insulin pump therapy for diabetes. Billerica, Mass.–based Insulet touts its Omnipod system as an easy-to-use tubeless insulin pump. It provides up to three days of non-stop insulin delivery, and users don’t need to handle a needle. Investor demand for the company’s stock is so strong that Insulet announced in November that it was up-sizing a private placement to $350 million in convertible senior notes due in 2024, up from a previous $300 million.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.
Was going to read this article but refuse to go through multiple clicks to see a list. Can you just give the list?
There’s a link on the opening slide where you can download a full spreadsheet of 100 companies and their stock performance. Hope that helps.